Design and biological characterization of novel cell-penetrating peptides preferentially targeting cell nuclei and subnuclear regions

Anja Gronewold, Mareike Horn and Ines Neundorf
Beilstein J. Org. Chem. 2018, 14, 1378–1388. https://doi.org/10.3762/bjoc.14.116

Supporting Information

Supporting Information File 1: Additional information.
Format: PDF Size: 614.1 KB Download

Cite the Following Article

Design and biological characterization of novel cell-penetrating peptides preferentially targeting cell nuclei and subnuclear regions
Anja Gronewold, Mareike Horn and Ines Neundorf
Beilstein J. Org. Chem. 2018, 14, 1378–1388. https://doi.org/10.3762/bjoc.14.116

How to Cite

Gronewold, A.; Horn, M.; Neundorf, I. Beilstein J. Org. Chem. 2018, 14, 1378–1388. doi:10.3762/bjoc.14.116

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 1.0 MB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Mai, L. D.; Wimberley, S. C.; Champion, J. A. Intracellular delivery strategies using membrane-interacting peptides and proteins. Nanoscale 2024, 16, 15465–15480. doi:10.1039/d4nr02093f
  • Al Musaimi, O. Peptide Therapeutics: Unveiling the Potential against Cancer-A Journey through 1989. Cancers 2024, 16, 1032. doi:10.3390/cancers16051032
  • Saraswat, S.; Chugh, A. Engraulisin: A novel marine derived cell penetrating peptide with activity against drug resistant bacteria. Biochimica et biophysica acta. Biomembranes 2023, 1866, 184255. doi:10.1016/j.bbamem.2023.184255
  • Langel, Ü. Targeting Specific Barriers. CPP, Cell-Penetrating Peptides; Springer International Publishing, 2023; pp 219–262. doi:10.1007/978-3-031-38731-9_9
  • Stillger, K.; Neundorf, I. Cell-permeable peptide-based delivery vehicles useful for subcellular targeting and beyond. Cellular signalling 2023, 109, 110796. doi:10.1016/j.cellsig.2023.110796
  • Asrorov, A. M.; Wang, H.; Zhang, M.; Wang, Y.; He, Y.; Sharipov, M.; Yili, A.; Huang, Y. Cell penetrating peptides: Highlighting points in cancer therapy. Drug development research 2023, 84, 1037–1071. doi:10.1002/ddr.22076
  • Mukherjee, A. G.; Wanjari, U. R.; Gopalakrishnan, A. V.; Bradu, P.; Biswas, A.; Ganesan, R.; Renu, K.; Dey, A.; Vellingiri, B.; El Allali, A.; Alsamman, A. M.; Zayed, H.; George Priya Doss, C. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023, 163, 114832. doi:10.1016/j.biopha.2023.114832
  • Urandur, S.; Sullivan, M. O. Peptide-Based Vectors: A Biomolecular Engineering Strategy for Gene Delivery. Annual review of chemical and biomolecular engineering 2023, 14, 243–264. doi:10.1146/annurev-chembioeng-101121-070232
  • Zeng, Z.; Li, C.; Zhu, Y.; Yang, L.; Shi, S.; Yang, F.; Feng, X. Dibenzocyclooctyne linked lysine-cyclodextrin for efficient intranucleus delivery of proteins. Journal of controlled release : official journal of the Controlled Release Society 2022, 352, 759–765. doi:10.1016/j.jconrel.2022.11.001
  • Grabeck, J.; Lützenburg, T.; Frommelt, P.; Neundorf, I. Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates. Molecules (Basel, Switzerland) 2022, 27, 6656. doi:10.3390/molecules27196656
  • Alkhashrom, S.; Kicuntod, J.; Stillger, K.; Lützenburg, T.; Anzenhofer, C.; Neundorf, I.; Marschall, M.; Eichler, J. A Peptide Inhibitor of the Human Cytomegalovirus Core Nuclear Egress Complex. Pharmaceuticals (Basel, Switzerland) 2022, 15, 1040. doi:10.3390/ph15091040
  • Lin, J.; Yang, K.; New, E. J. doi:10.1002/9781119749844.ch3
  • Fu, C.; Yu, L.; Miao, Y.; Liu, X.; Yu, Z.; Wei, M. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?. Acta pharmaceutica Sinica. B 2022, 13, 498–516. doi:10.1016/j.apsb.2022.07.020
  • Kuznik, N. C.; Solozobova, V.; Lee, I. I.; Jung, N.; Yang, L.; Nienhaus, K.; Ntim, E. A.; Rottenberg, J. T.; Muhle-Goll, C.; Kumar, A. R.; Peravali, R.; Gräßle, S.; Gourain, V.; Deville, C.; Cato, L.; Neeb, A.; Dilger, M.; Cramer von Clausbruch, C. A.; Weiss, C.; Kieffer, B.; Nienhaus, G. U.; Brown, M.; Bräse, S.; Cato, A. C. B. A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway. iScience 2022, 25, 104175. doi:10.1016/j.isci.2022.104175
  • Cerrato, C. P.; Langel, Ü. An update on cell-penetrating peptides with intracellular organelle targeting. Expert opinion on drug delivery 2022, 19, 133–146. doi:10.1080/17425247.2022.2034784
  • Gessner, I.; Klimpel, A.; Neundorf, I. Synthesis of Cell-Penetrating Peptide Coated Silica Nanoparticles and Their Physicochemical and Biological Characterization. Methods in molecular biology (Clifton, N.J.) 2021, 2383, 105–117. doi:10.1007/978-1-0716-1752-6_7
  • Lin, J.; Yang, K.; New, E. J. Strategies for organelle targeting of fluorescent probes. Organic & biomolecular chemistry 2021, 19, 9339–9357. doi:10.1039/d1ob01447a
  • Kim, G. C.; Cheon, D. H.; Lee, Y. Challenge to overcome current limitations of cell-penetrating peptides. Biochimica et biophysica acta. Proteins and proteomics 2021, 1869, 140604. doi:10.1016/j.bbapap.2021.140604
  • Khan, M. M.; Filipczak, N.; Torchilin, V. P. Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer. Journal of controlled release : official journal of the Controlled Release Society 2020, 330, 1220–1228. doi:10.1016/j.jconrel.2020.11.028
  • Díaz-Gómez, J. L.; Neundorf, I.; López-Castillo, L.-M.; Castorena-Torres, F.; Serna-Saldívar, S. O.; García-Lara, S. In Silico Analysis and In Vitro Characterization of the Bioactive Profile of Three Novel Peptides Identified from 19 kDa α-Zein Sequences of Maize. Molecules (Basel, Switzerland) 2020, 25, 5405. doi:10.3390/molecules25225405
Other Beilstein-Institut Open Science Activities